Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Short-term Investments (2021 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Short-term Investments for 3 consecutive years, with $228.7 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Short-term Investments rose 83.98% year-over-year to $228.7 million, compared with a TTM value of $228.7 million through Sep 2023, up 83.98%, and an annual FY2022 reading of $139.9 million, up 18.26% over the prior year.
  • Short-term Investments was $228.7 million for Q3 2023 at Terns Pharmaceuticals, up from $204.7 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $228.7 million in Q3 2023 and bottomed at $96.8 million in Q1 2021.
  • Average Short-term Investments over 3 years is $135.1 million, with a median of $118.3 million recorded in 2021.
  • The sharpest move saw Short-term Investments rose 4.69% in 2022, then skyrocketed 83.98% in 2023.
  • Year by year, Short-term Investments stood at $118.3 million in 2021, then rose by 18.26% to $139.9 million in 2022, then surged by 63.5% to $228.7 million in 2023.
  • Business Quant data shows Short-term Investments for TERN at $228.7 million in Q3 2023, $204.7 million in Q2 2023, and $113.2 million in Q1 2023.